| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Robert Lefkowitz | Q80910 |
| P2093 | author name string | Louis M Luttrell | |
| P433 | issue | Pt 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 455-465 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Journal of Cell Science | Q1524177 |
| P1476 | title | The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals | |
| P478 | volume | 115 |
| Q34583782 | (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain. |
| Q41979400 | (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility |
| Q28547577 | 14-3-3 Proteins Buffer Intracellular Calcium Sensing Receptors to Constrain Signaling |
| Q38653533 | A Bright Future for Serial Femtosecond Crystallography with XFELs. |
| Q90210858 | A Genetically Encoded Fluorescent Sensor Enables Rapid and Specific Detection of Dopamine in Flies, Fish, and Mice |
| Q33779634 | A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. |
| Q27936217 | A calcineurin-dependent switch controls the trafficking function of α-arrestin Aly1/Art6. |
| Q33249099 | A critical role for endocytosis in Wnt signaling |
| Q34218573 | A high-content, live-cell, and real-time approach to the quantitation of ligand-induced β-Arrestin2 and Class A/Class B GPCR mobilization. |
| Q34298001 | A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity |
| Q33401598 | A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease |
| Q24299867 | A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization |
| Q38695082 | A roadmap to understanding toll pathway changes: an educational primer for use with "regulation of toll signaling and inflammation by β-arrestin and the SUMO protease Ulp1". |
| Q24337712 | ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4 |
| Q24647504 | ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor |
| Q27301914 | Acoustofluidic chemical waveform generator and switch. |
| Q36110572 | Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways |
| Q38234911 | Adrenal adrenoceptors in heart failure. |
| Q38125685 | Adrenergic mechanism in the control of endothelial function |
| Q34304875 | Adrenergic receptor activation involves ATP release and feedback through purinergic receptors |
| Q35213193 | Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. |
| Q42549992 | Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors |
| Q37156680 | Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models |
| Q33632079 | Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. |
| Q38739512 | An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice |
| Q34496676 | Angiotensin II receptors and drug discovery in cardiovascular disease |
| Q41195003 | Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis |
| Q35849415 | Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle. |
| Q34672108 | Arrestins differentially regulate histamine- and oxytocin-evoked phospholipase C and mitogen-activated protein kinase signalling in myometrial cells. |
| Q35999193 | Assessing Gonadotropin Receptor Function by Resonance Energy Transfer-Based Assays |
| Q33700017 | Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling |
| Q36512963 | Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder |
| Q34324913 | Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. |
| Q42420177 | Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. |
| Q24653656 | Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction |
| Q36445260 | Beta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscle |
| Q40025332 | Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. |
| Q64097803 | Biased Signaling and Allosteric Modulation at the FSHR |
| Q47142451 | Biventricular differences in β-adrenergic receptor signaling following burn injury. |
| Q22001506 | CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B |
| Q35106596 | CCR5 conformations are dynamic and modulated by localization, trafficking and G protein association |
| Q38432470 | CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease. |
| Q41382247 | CO2 pneumoperitoneum preserves β-arrestin 2 content and reduces high mobility group box-1 (HMGB-1) expression in an animal model of peritonitis. |
| Q37105011 | Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells |
| Q52806005 | Canonical TSH Regulation of Cathepsin-Mediated Thyroglobulin Processing in the Thyroid Gland of Male Mice Requires Taar1 Expression. |
| Q35818355 | Cargo- and compartment-selective endocytic scaffold proteins |
| Q33634673 | Caveolae-dependent internalization and homologous desensitization of VIP/PACAP receptor, VPAC₂, in gastrointestinal smooth muscle |
| Q46007992 | Caveolin-1 restoration by cholesterol enhances the inhibitory effect of simvastatin on arginine vasopressin-induced cardiac fibroblasts proliferation. |
| Q64285404 | Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells |
| Q90549248 | Cell-Free Protein Synthesis: A Promising Option for Future Drug Development |
| Q26827583 | Cell-surface receptors transactivation mediated by g protein-coupled receptors |
| Q36980604 | Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system |
| Q34614905 | Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes. |
| Q36184275 | Chemokine receptor internalization and intracellular trafficking |
| Q92960322 | Circularly Permuted Fluorescent Protein-Based Indicators: History, Principles, and Classification |
| Q37529047 | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5. |
| Q24530597 | Clathrin-dependent endocytosis |
| Q42136849 | Clathrin-independent internalization of the human histamine H1-receptor in CHO-K1 cells |
| Q37983747 | Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism |
| Q30505951 | Cofilin under control of β-arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning |
| Q33869206 | Comparative muscle transcriptome associated with carcass traits of Nellore cattle. |
| Q36191614 | Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. |
| Q30557505 | Conformational biosensors reveal GPCR signalling from endosomes. |
| Q36634318 | Contributions of protein kinases and β-arrestin to termination of protease-activated receptor 2 signaling |
| Q53682448 | Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development. |
| Q34551853 | Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation. |
| Q37162371 | Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils |
| Q35973795 | Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation |
| Q24800189 | Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils |
| Q89009026 | Decoding the chemotactic signal |
| Q35645970 | Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma |
| Q34064133 | Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. |
| Q37147052 | Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells |
| Q41991082 | Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation |
| Q24294614 | Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference |
| Q58698789 | Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease |
| Q43075987 | Designing Safer Analgesics via μ-Opioid Receptor Pathways |
| Q53400478 | Development of full sweet, umami, and bitter taste responsiveness requires Regulator of G protein Signaling-21 (RGS21). |
| Q33819496 | Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor |
| Q35076051 | Differential activation and trafficking of micro-opioid receptors in brain slices |
| Q37282807 | Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes |
| Q42126128 | Differential regulation of endosomal GPCR/β-arrestin complexes and trafficking by MAPK |
| Q36270932 | Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors |
| Q47682289 | Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. |
| Q35132371 | Distinct pathways of ERK1/2 activation by hydroxy-carboxylic acid receptor-1 |
| Q36579520 | Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini |
| Q37550019 | Diversity in arrestin function |
| Q90075720 | Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA |
| Q60141581 | Dopamine: Functions, Signaling, and Association with Neurological Diseases |
| Q34080461 | Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics. |
| Q34803218 | EFR3s are palmitoylated plasma membrane proteins that control responsiveness to G-protein-coupled receptors |
| Q39554030 | ET-1 induced Elevation of intracellular calcium in clonal neuronal and embryonic kidney cells involves endogenous endothelin-A receptors linked to phospholipase C through Gα(q/11) |
| Q39188292 | Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells |
| Q51872392 | Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia. |
| Q41177526 | Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation |
| Q41906789 | Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. |
| Q42791086 | Essential role for beta-arrestin 2 in the regulation of Xenopus convergent extension movements |
| Q34804942 | Expression Analysis of Visual Arrestin gene during Ocular Development of Olive Flounder (Paralichthys olivaceus). |
| Q34089093 | FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury |
| Q90655306 | FVIIa (Factor VIIa) Induces Biased Cytoprotective Signal in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 Site |
| Q64997269 | Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system. |
| Q38698390 | Feedback regulation of G protein-coupled receptor signaling by GRKs and arrestins. |
| Q41952624 | Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis |
| Q35999789 | Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. |
| Q42407015 | Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway |
| Q34544364 | Functional competence of a partially engaged GPCR-β-arrestin complex |
| Q37863171 | Functional relevance of biased signaling at the angiotensin II type 1 receptor |
| Q39021630 | Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets |
| Q35264421 | Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. |
| Q36692097 | G protein coupled receptor structure and activation |
| Q28578948 | G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling |
| Q35682949 | G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. |
| Q36914223 | G protein-coupled receptor-promoted trafficking of Gbeta1gamma2 leads to AKT activation at endosomes via a mechanism mediated by Gbeta1gamma2-Rab11a interaction |
| Q35065927 | G protein-coupled receptors--recent advances |
| Q34735704 | G-protein-coupled receptor phosphorylation: where, when and by whom |
| Q35566599 | G-protein-coupled receptors: past, present and future. |
| Q33828719 | GPCRs and cancer |
| Q24630455 | GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects |
| Q33707710 | GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner |
| Q64252945 | GRKs and β-Arrestins: "Gatekeepers" of Mitochondrial Function in the Failing Heart |
| Q34708318 | Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma |
| Q46406604 | Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK. |
| Q52642716 | Genomic and transcriptomic comparison of allergen and silver nanoparticle-induced mast cell degranulation reveals novel non-immunoglobulin E mediated mechanisms. |
| Q35766985 | Gi-biased β2AR signaling links GRK2 upregulation to heart failure |
| Q34073929 | GnRH signaling, the gonadotrope and endocrine control of fertility |
| Q38264143 | Gq protein-induced apoptosis is mediated by AKT kinase inhibition that leads to protein kinase C-induced c-Jun N-terminal kinase activation |
| Q37087686 | Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). |
| Q39180630 | Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration |
| Q42377918 | Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment |
| Q39414464 | Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways |
| Q34028196 | Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors |
| Q40983016 | Homogeneous time-resolved fluorescence-based assay to monitor extracellular signal-regulated kinase signaling in a high-throughput format |
| Q35227742 | Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response |
| Q26821954 | Human β-cell proliferation and intracellular signaling: part 3 |
| Q35589613 | IL-13 desensitizes β2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism |
| Q43256736 | Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist |
| Q38758506 | Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line |
| Q34467542 | Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling |
| Q35459699 | Identifying functional gene regulatory network phenotypes underlying single cell transcriptional variability |
| Q38720041 | Identifying ligands at orphan GPCRs: current status using structure-based approaches |
| Q37551248 | Illuminating the life of GPCRs |
| Q38175342 | Importing, caring, breeding, genotyping, and phenotyping a genetic mouse in a Chinese university |
| Q37014120 | Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure. |
| Q35490940 | Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation |
| Q34092070 | Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation. |
| Q61796045 | Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury |
| Q38007632 | Inflammation and lipid signaling in the etiology of insulin resistance |
| Q36518292 | Information Transfer in Gonadotropin-releasing Hormone (GnRH) Signaling: EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)-MEDIATED FEEDBACK LOOPS CONTROL HORMONE SENSING. |
| Q26795668 | Ins and outs of GPCR signaling in primary cilia |
| Q34888305 | Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of β-arrestin2 |
| Q33716607 | Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis |
| Q64065904 | Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling |
| Q38287475 | Intracellular signaling mechanisms of the melanocortin receptors: current state of the art. |
| Q38206385 | Involvement of bradykinin in brain edema development after ischemic stroke |
| Q38053088 | Involvement of β-arrestins in cancer progression |
| Q37249506 | Kisspeptin/KISS1R System in Breast Cancer |
| Q30479618 | Leukocyte migration and graft-versus-host disease |
| Q42096462 | Ligand binding to a G protein-coupled receptor captured in a mass spectrometer |
| Q37209196 | Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling |
| Q35090466 | Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. |
| Q24314383 | Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with Galphas |
| Q58435171 | Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9 |
| Q34139164 | Mapping the putative G protein-coupled receptor (GPCR) docking site on GPCR kinase 2: insights from intact cell phosphorylation and recruitment assays |
| Q48622632 | Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon |
| Q26745953 | Melanocortin 1 Receptor: Structure, Function, and Regulation |
| Q37610141 | Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. |
| Q33631599 | Minireview: Spatial Programming of G Protein-Coupled Receptor Activity: Decoding Signaling in Health and Disease |
| Q48485598 | Mobility of acetylcholine receptors in command Helix lucorum neurons in a cellular analog of habituation |
| Q35158385 | Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors |
| Q43165436 | Molecular Evidence for Convergence and Parallelism in Evolution of Complex Brains of Cephalopod Molluscs: Insights from Visual Systems. |
| Q33751029 | Molecular and anatomical signatures of sleep deprivation in the mouse brain |
| Q38011850 | Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance |
| Q38795040 | Molecular cloning and functional characterization of the diapause hormone receptor in the corn earworm Helicoverpa zea. |
| Q64895618 | Molecular mechanism of modulating arrestin conformation by GPCR phosphorylation. |
| Q37326059 | Molecular mechanisms of gonadotropin-releasing hormone signaling: integrating cyclic nucleotides into the network. |
| Q40110003 | Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. |
| Q43195607 | Monitoring protein conformational changes and dynamics using stable-isotope labeling and mass spectrometry |
| Q34361815 | Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells |
| Q36712009 | Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X Signaling |
| Q36984756 | Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins |
| Q36341679 | Mu opioid receptor regulation and opiate responsiveness |
| Q82606560 | Multiple Gi proteins participate in nerve growth factor-induced activation of c-Jun N-terminal kinases in PC12 cells |
| Q36115098 | Multiple ligand-specific conformations of the β2-adrenergic receptor |
| Q35275073 | Multiplex single-molecule interaction profiling of DNA-barcoded proteins |
| Q36738475 | NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats |
| Q55670717 | Nephrogenic syndrome of inappropriate antidiuresis |
| Q40718891 | Neural induction in the absence of organizer in salamanders is mediated by MAPK |
| Q48104478 | Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. |
| Q64229777 | New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis |
| Q35671415 | New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors |
| Q37201202 | Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. |
| Q46757075 | Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets. |
| Q33612895 | Novel insights into G protein and G protein-coupled receptor signaling in cancer |
| Q33727162 | Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy |
| Q36211468 | Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. |
| Q38085387 | Opioid receptor interacting proteins and the control of opioid signaling. |
| Q37938862 | Opioid receptor trafficking and signaling: what happens after opioid receptor activation? |
| Q35005680 | PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization |
| Q26798005 | PTH receptor-1 signalling-mechanistic insights and therapeutic prospects |
| Q39249398 | Pancreatic islet inflammation: an emerging role for chemokines |
| Q43146019 | Perturbing dynamin reveals potent effects on the Drosophila circadian clock |
| Q40515487 | Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1. |
| Q35580796 | Phosphorylation of the deubiquitinase USP20 by protein kinase A regulates post-endocytic trafficking of β2 adrenergic receptors to autophagosomes during physiological stress |
| Q39333514 | Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists |
| Q39484125 | Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14. |
| Q35567393 | Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR). |
| Q27012822 | Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease |
| Q37974268 | Probing heterotrimeric G protein activation: applications to biased ligands. |
| Q36440738 | Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation |
| Q36824668 | Prostacyclin receptor regulation--from transcription to trafficking |
| Q35057786 | Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways |
| Q27310866 | Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons |
| Q36143895 | Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors |
| Q99405003 | Regulation of CXCR6 Expression on Adipocytes and Osteoblasts Differentiated from Human Adipose Tissue-Derived Mesenchymal Stem Cells |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q33642051 | Regulation of GPR54 signaling by GRK2 and {beta}-arrestin |
| Q33625259 | Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. |
| Q33642196 | Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle |
| Q50116104 | Relationship between G proteins coupled receptors and tight junctions |
| Q35839082 | Releasable SNAP-tag probes for studying endocytosis and recycling |
| Q28552204 | Release of GTP Exchange Factor Mediated Down-Regulation of Abscisic Acid Signal Transduction through ABA-Induced Rapid Degradation of RopGEFs |
| Q28266829 | Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors |
| Q33589255 | Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery |
| Q39321350 | Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases |
| Q39629692 | Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia |
| Q38672719 | Roles of phosphorylation-dependent and -independent mechanisms in the regulation of histamine H2 receptor by G protein-coupled receptor kinase 2. |
| Q39648096 | Roles of the α1A-adrenergic receptor carboxyl tail in protein kinase C-induced phosphorylation and desensitization. |
| Q45081795 | Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium |
| Q90700670 | Rules of Engagement: GPCRs and G Proteins |
| Q35126954 | S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness |
| Q36562076 | SET protein interacts with intracellular domains of the gonadotropin-releasing hormone receptor and differentially regulates receptor signaling to cAMP and calcium in gonadotrope cells. |
| Q33642724 | Selective regulation of H1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells. |
| Q24647599 | Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice |
| Q44343075 | Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor. |
| Q64949661 | Serial Femtosecond Crystallography of G Protein-Coupled Receptors. |
| Q36647024 | Serotonin receptor signaling and regulation via β-arrestins |
| Q34402623 | Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo |
| Q28731687 | Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations |
| Q33890786 | Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery |
| Q35951259 | Seven-transmembrane receptors and ubiquitination |
| Q43783930 | Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time |
| Q30677207 | Single Molecule Imaging Deciphers the Relation between Mobility and Signaling of a Prototypical G Protein-coupled Receptor in Living Cells |
| Q50042320 | Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation. |
| Q47344641 | Slowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence |
| Q36735740 | Smoothened determines β-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium |
| Q36565309 | Sorting nexin 27 interacts with Fzd7 and mediates Wnt signalling |
| Q89517789 | Spatiotemporal dynamic monitoring of fatty acid-receptor interaction on single living cells by multiplexed Raman imaging |
| Q36051502 | Specificity of arrestin subtypes in regulating airway smooth muscle G protein-coupled receptor signaling and function |
| Q38457000 | Synthetic melatoninergic ligands: achievements and prospects. |
| Q39106190 | TSHR as a therapeutic target in Graves' disease |
| Q37769121 | Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link |
| Q90265191 | Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach |
| Q38866310 | Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146. |
| Q34947494 | Temporal profiling of orexin receptor-arrestin-ubiquitin complexes reveals differences between receptor subtypes |
| Q47240000 | The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5. |
| Q35249092 | The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice |
| Q36976809 | The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha |
| Q55010002 | The Phosphorylation of CCR6 on Distinct Ser/Thr Residues in the Carboxyl Terminus Differentially Regulates Biological Function. |
| Q50285621 | The Role of G Protein-coupled Receptor Kinases in Cancer |
| Q47107303 | The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection |
| Q39806707 | The Viral G Protein-Coupled Receptor ORF74 Hijacks β-Arrestins for Endocytic Trafficking in Response to Human Chemokines |
| Q36973488 | The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR. |
| Q37200963 | The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex |
| Q35047674 | The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology |
| Q24657333 | The genetic design of signaling cascades to record receptor activation |
| Q33370697 | The information highways of a biotechnological workhorse--signal transduction in Hypocrea jecorina |
| Q37131419 | The origins of diversity and specificity in g protein-coupled receptor signaling |
| Q38980205 | The regulation of β-adrenergic receptor-mediated PKA activation by substrate stiffness via microtubule dynamics in human MSCs |
| Q30506209 | The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment |
| Q40463546 | The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. |
| Q40032446 | The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation |
| Q37281661 | The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. |
| Q59807304 | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling |
| Q88555515 | Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2 |
| Q27007472 | Tools for GPCR drug discovery |
| Q37627277 | Trafficking and signalling of gonadotrophin-releasing hormone receptors: an automated imaging approach |
| Q36207533 | Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain |
| Q44969005 | Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases. |
| Q33553754 | Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization |
| Q28568668 | Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2 |
| Q34494645 | Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function. |
| Q41535363 | Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy |
| Q91939949 | [Nephrogenic syndrome of inappropriate antidiuresis] |
| Q30476507 | beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae |
| Q37000177 | beta-Arrestin 2: a Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes |
| Q34513767 | beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. |
| Q30477945 | beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity |
| Q35062148 | beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice |
| Q37527105 | beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. |
| Q24317611 | c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms |
| Q90084148 | β-Arrestin 2 mediates arginine vasopressin-induced IL-6 induction via the ERK1/2-NF-κB signal pathway in murine hearts |
| Q48252525 | β-Arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells |
| Q59805371 | β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders |
| Q34219369 | β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma |
| Q33994385 | β-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR/ABL H4 acetylation |
| Q36755034 | β-Arrestins Negatively Regulate the Toll Pathway in Shrimp by Preventing Dorsal Translocation and Inhibiting Dorsal Transcriptional Activity |
| Q38114223 | β-Arrestins in the immune system |
| Q45167801 | β-arrestin 2 regulates Toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β. |
| Q37578793 | β-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia |
| Q37630356 | β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions |
| Q54117203 | β-arrestin2 Affects Cardiac Progenitor Cell Survival through Cell Mobility and Tube Formation in Severe Hypoxia. |
| Q27306187 | β2 adrenergic receptor fluorescent protein fusions traffic to the plasma membrane and retain functionality |
Search more.